San Bruno, CA. (PRWEB) March 04, 2015 PRC Clinical, a full-service, Contract Research Organization (CRO) headquartered in the San Francisco Bay Area, will exhibit and present at the Outsourcing in Clinical Trials (OCT) Israel Conference 2015 on March 25th and 26th in Tel Aviv, Israel. PRC Clinical seeks to build relationships with Israeli life science companies seeking to conduct U.S. Food and Drug Administration (FDA) clinical trials. The companys services span all phases of human trials, from Phase I studies in healthy subjects, through to Phase II, dose-finding and safety studies to larger Phase III and post-marketing studies. Israel is one of the major emerging markets in terms of healthcare and pharmaceuticals worldwide. According to the Israeli Ministry of Economy, Israel is the fourth largest supplier of pharmaceutical products to the U.S. market. We are familiar with the Israeli and U.S. drug development industry and regulatory requirements, said Tony Taricco, President and Chief Operating Officer at PRC Clinical. We have significant CRO experience conducting trials from early phase through to regulatory submission across a wide range of different therapeutic areas. PRC Clinical will present its clinical services at the event, along with its partner, Statistics & Data Corporation (SDC). SDC … Continue reading →